Becker's Healthcare January 26, 2022
As an early investor in commercial genetic testing company 23andMe, Google bet on an experiment that has since paid off, CNBC reported Jan. 25.
Less than two decades ago, the cost to process a person’s genetic profile was $14 million. Now, companies including Ancestry.com and 23andMe sell kits starting at $99.
In 2013, 23andMe had raised $50 million from investors, including Google. That same year it was placed on a two-year review by the FDA, which investigated whether the company could reasonably make certain health claims to customers. In October 2015, 23andMe got approval from the...
Today's Sponsors
Today's Sponsor